The Pediatric infectious disease journal
Efficacy and Safety of Daptomycin in the Neonatal Population.
Celia Permuy, Jone Ruiz-Azcárate, Laura Sánchez García, Teresa Del Rosal, Cristina Jiménez, Iker Falces, Cristina Calvo, Adelina Pellicer
Published: 202510.1097/INF.0000000000005136
Abstract
BACKGROUND: Gram-positive sepsis remains a leading cause of morbidity and mortality in neonates. Vancomycin is the standard of care, yet drug monitoring challenges and rising resistance demand alternatives. Daptomycin has potent bactericidal activity…
Preview only. Read the full abstract at the source